During the past decade, John Ochsner Heart & Vascular Institute conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 2 clinical trials were completed. i.e. 200% of trials that started reached the finish line.

Out of the total clinical trials conducted in "John Ochsner Heart & Vascular Institute" #1 sponsor was "Medtronic Cardiac Rhythm and Heart Failure" with 4 trials, followed by "Eko Devices, Inc." with 1 trials sponsored, "Lung Biotechnology PBC" with 1 trials sponsored, "Pfizer" with 1 trials sponsored and "ReCor Medical, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "John Ochsner Heart & Vascular Institute" #1 collaborator was "INTERMACS" with 1 trials as a collaborator and "Labatt Family Heart Centre" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "John Ochsner Heart & Vascular Institute" are "Chronic Heart Failure" (3 trials), "Cardiovascular Diseases" (2 trials), "Atrial Flutter" (1 trials), "Fetal Hydrops" (1 trials) and "Heart Diseases" (1 trials). Many other conditions were trialed in "John Ochsner Heart & Vascular Institute" in a lesser frequency.

Most popular intervention types in "John Ochsner Heart & Vascular Institute" are "Device" (6 trials), "Other" (2 trials), "Procedure" (2 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Control LVAD" (2 trials), "HeartWare® VAS" (2 trials), "Beraprost Sodium 314d Modified Release Tablets" (1 trials), "HeartWare HVAD" (1 trials) and "HeartWare® VAS (HVAD)" (1 trials). Other intervention names were less common.

The vast majority of trials in "John Ochsner Heart & Vascular Institute" are 8 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "John Ochsner Heart & Vascular Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in John Ochsner Heart & Vascular Institute, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in John Ochsner Heart & Vascular Institute, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 5 trials that are defined as “Not Applicable".